Element Materials Technology/Jones Microbiology InstituteNorth Liberty, Iowa, United States
Disclosure(s): No financial relationships to disclose
316 - In vitro Activity of Gepotidacin against Klebsiella pneumoniae, Including Molecularly Characterized ESBL and Carbapenemase positive Subsets Causing Urinary Tract Infections in the United States (2019-2022)
Friday, October 18, 202412:15 PM – 12:20 PM US PT